Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
12/18/20 | S-3 | Registration statement for specified transactions by certain issuers |
![]() ![]() |
29 | |
12/14/20 | 8-K | Current report filing |
![]() ![]() |
59 | |
12/08/20 | 8-K | Current report filing |
![]() ![]() |
31 | |
12/07/20 | 8-K | Current report filing |
![]() ![]() |
40 | |
12/04/20 | 8-K | Current report filing |
![]() ![]() |
7 | |
11/16/20 | 8-K | Current report filing |
![]() ![]() |
57 | |
11/12/20 | 8-K | Current report filing |
![]() ![]() |
33 | |
11/10/20 | 8-K | Current report filing |
![]() ![]() |
48 | |
11/09/20 | 8-K | Current report filing |
![]() ![]() |
10 | |
11/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() ![]() |
![]() ![]() ![]() |
56 |